Literature DB >> 2060330

Chronic tuberculous empyema with bronchopleural fistula resulting in treatment failure and progressive drug resistance.

M D Iseman1, L A Madsen.   

Abstract

We treated five patients with a past history of tuberculous pleural infection that led to chronic, quiescent, loculated empyema. Reactivation of TB was associated with formation of BPF and recovery of drug-susceptible Mycobacterium tuberculosis from sputum. All patients had recurrence of positive sputum cultures that yielded tubercle bacilli resistant to drugs they were receiving. The lungs demonstrated gross thickening with calcification of both visceral and parietal pleura. Two patients underwent retreatment chemotherapy followed by decortication-empyemectomy and lung resection surgery; both are now culture-negative for TB. One patient received retreatment chemotherapy but refused surgery; he remains clinically stable with negative sputum cultures. Two other patients' organisms became drug-resistant and they remain sputum-culture positive. We believe that thick, calcified pleural walls limit penetration of drugs into the infected empyema space, resulting in suboptimal drug concentrations and drug resistance. Intensified chemotherapy and surgical intervention should be considered in these cases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060330     DOI: 10.1378/chest.100.1.124

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 2.  Tuberculous Pleural Effusion.

Authors:  Leah A Cohen; Richard W Light
Journal:  Turk Thorac J       Date:  2015-01-01

3.  The population dynamics of antimicrobial chemotherapy.

Authors:  M Lipsitch; B R Levin
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

4.  A PERSISTENT TRANSPLEURAL FISTULOUS COMMUNICATION BETWEEN LUNG AND CHEST WALL.

Authors:  A K Rajput; Vasu Vardhan; K E Rajan; S C Tewari
Journal:  Med J Armed Forces India       Date:  2017-06-10

5.  Isoniazid pharmacokinetics in children treated for respiratory tuberculosis.

Authors:  H S Schaaf; D P Parkin; H I Seifart; C J Werely; P B Hesseling; P D van Helden; J S Maritz; P R Donald
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

Review 6.  Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy.

Authors:  Digby F Warner; Valerie Mizrahi
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

7.  Treatment of a tuberculous empyema with simultaneous oral and intrapleural antituberculosis drugs.

Authors:  Richard Long; James Barrie; Kenneth Stewart; Charles A Peloquin
Journal:  Can Respir J       Date:  2008 Jul-Aug       Impact factor: 2.409

8.  Treatment of Tuberculous Empyema by Intrathoracic Transposition of a Latissimus Dorsi Muscle Flap.

Authors:  Byeong Jun Kim; In Pyo Hong; Chan Min Chung; Woo Sik Kim
Journal:  Arch Plast Surg       Date:  2016-01-15

9.  Adult thoracic empyema: A comparative analysis of tuberculous and nontuberculous etiology in 75 patients.

Authors:  Somenath Kundu; Subhra Mitra; Subhasis Mukherjee; Soumya Das
Journal:  Lung India       Date:  2010-10

10.  Comparison of closed-chest drainage with rib resection closed drainage for treatment of chronic tuberculous empyema.

Authors:  Yong Fang; Heping Xiao; Wei Sha; Haili Hu; Xiaofang You
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.